Data Implementation Manager, ODAIA

CA$140-175k

+ Stock Option Grants

SQL
AWS
Python
Salesforce
Snowflake
Senior and Expert level
Toronto
Remote from Canada
ODAIA

AI-powered intelligence for pharma commerical teams

Open for applications

ODAIA

AI-powered intelligence for pharma commerical teams

101-200 employees

HealthcareB2BArtificial IntelligenceBig dataSaaSData AnalysisScience

Open for applications

CA$140-175k

+ Stock Option Grants

SQL
AWS
Python
Salesforce
Snowflake
Senior and Expert level
Toronto
Remote from Canada

101-200 employees

HealthcareB2BArtificial IntelligenceBig dataSaaSData AnalysisScience

Company mission

To reduce patients time to therapy by enabling meaningful interactions with healthcare providers, powered by AI-driven, human-centric software.

Company mission

To reduce patients time to therapy by enabling meaningful interactions with healthcare providers, powered by AI-driven, human-centric software.

Top investors

49% employee growth in 12 months

Our take

ODAIA have been growing fast in recent years. The company began in the University of Toronto with an intensive period of R&D in AI, journey mapping, and process mining. From there, the ODAIA commercial insights platform for the pharmaceuticals industry was born. Its MAPTUAL solution uses AI and predictive analytics on a vast spread of data to segment and target physicians, thereby driving up customer engagement.

Its rapid growth can be put down, in part, to a widespread shift in the way healthcare providers (HCPs) interact with Pharma, precipitated by the COVID pandemic. With on-site visits restricted, pharma reps needed to seek out different ways of forging meaningful client connections. What we’re seeing now is pharma messaging developing into more detailed, tailored forms of HCP support. As we’ve seen with marketing more generally, big data analytics is a phenomenally powerful tool for maintaining this competitive, tailored edge and funding awarded in 2023 proves that ODAIA's AI is being tipped as a solution for the "bottleneck" in pharma delivery and testing.

This means that ODAIA is blazing what is likely to prove an impressive trail in the new model of Pharma/HCP relations. Offering a more streamlined, modern method of targeting and value production, ODAIA is likely to prove an increasingly crucial player going forward in a highly lucrative market.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Leadership Opportunities: If you’re willing to invest in yourself, we’re willing to invest in you! As a fast growing company, there's lots of opportunity for career advancement and personal development.
  • Flexible Working Hours: We focus on what we achieve and not the number of hours we clock. We trust our employees and empower them to shape their work themselves so that they can achieve the best possible results
  • Remote Work: We are a remote-first company with plans for in-person collaborative work sessions post-covid. We leverage many synchronous and asynchronous communication tools as well
  • Flex Vacation Policy: Our employees can take time off whenever they want - as long as they get their work done, get the time approved, and get things covered while they're away. One of our core values is trusting and respecting each other.
  • Health Benefits: We offer top-notch health benefits for medical, dental, vision care, prescription drug coverage, travel insurance and alternative treatments such as acupuncture and chiropractic services.

Funding (last 2 of 4 rounds)

May 2023

$25m

SERIES B

Feb 2022

$13.8m

SERIES A

Total funding: $43.4m

This company has top investors

Leadership

Philip Poulidis

(Co-Founder & CEO)

Veteran public company executive leader, board member, and startup CEO with experience in the IoT, Semiconductor, Digital Health, and Enterprise SaaS markets.